These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 959097)

  • 1. Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.
    Alexander WD; Wensley RT; Price G; Hartog M
    Postgrad Med J; 1976 May; 52(607):251-3. PubMed ID: 959097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity in diabetics before and after chlorpropamide therapy.
    Mehrotra TN; Mital HS; Mishra SD; Singh VS; Kumar M
    J Assoc Physicians India; 1978 May; 26(5):375-8. PubMed ID: 730717
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
    Almér LO
    Thromb Res; 1984 Jul; 35(1):19-25. PubMed ID: 6433503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sulfonylureas on lipid levels in diabetic patients].
    Sgambato S; Cristiano L; Torella R
    Rass Int Clin Ter; 1968 Apr; 48(8):455-62. PubMed ID: 5736035
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antidiuretic action of chlorpropamide (Diabinese) in a case of combined diabetes mellitus and diabetes insipidus].
    Mazovetskiĭ AG; Danilova NS
    Probl Endokrinol (Mosk); 1972; 18(2):63-5. PubMed ID: 5024495
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Almér LO
    Acta Endocrinol Suppl (Copenh); 1980; 239():53-5. PubMed ID: 6159764
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.
    Reaven G; Dray J
    Diabetes; 1967 Jul; 16(7):487-92. PubMed ID: 6028757
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Treatment of maturity-onset diabetes.
    Clarke BF; Campbell IW
    Lancet; 1975 Mar; 1(7906):580-1. PubMed ID: 47059
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoglycemic treatments and the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations.
    Gamba G; Grignani G; Biancardi M; De Marco R; Grassi M; Ferrari E
    Acta Diabetol Lat; 1983; 20(1):63-70. PubMed ID: 6858544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of placebo in long-term chlorpropamide-treated diabetics.
    Lev-Ran A
    Diabetologia; 1974 Jun; 10(3):197-200. PubMed ID: 4602675
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of blood serum lipid and lipoprotein indices in diabetes mellitus, treated with chlorpropamide and butamide].
    Sil'nitskiĭ PA
    Probl Endokrinol (Mosk); 1968; 14(3):9-13. PubMed ID: 5734589
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of glibenclamide and chlorpropamide in the treatment of non-obese maturity onset diabetics.
    Johnston AT; Ireland JT
    Postgrad Med J; 1970 Dec; ():Suppl:98-100. PubMed ID: 5500517
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorpropamide alcohol flushing.
    Barnett AH; Pyke DA
    Lancet; 1981 Jan; 1(8213):222. PubMed ID: 6109887
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the blood chlorpropamide concentration critical in chlorpropamide alcohol flush?
    Jerntorp P; Almér LO; Melander A
    Lancet; 1981 Jan; 1(8212):165-6. PubMed ID: 6109853
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet.
    Clarke BF; Campbell IW
    Br Med J; 1977 Dec; 2(6102):1576-8. PubMed ID: 589351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.